💥 Zero Bullshit
Chapitre 04

Metastasis

To raise the famous €8M in bonds from private individuals, you need to be an SA, a French public limited company. Galeon is an SAS, a simplified joint-stock company. Except that the shareholding is not in order: a co-founder, Frédéric Da Ros, is in open conflict with Brotons over governance, the valuation of the shares and the terms of his departure.

Da Ros is not a minor partner. Co-founder and former chief technology officer, he holds 150K class A shares, the ones with tenfold voting rights: 10 votes per share. That’s 1.5M votes at shareholder meetings, against 6.2M for Brotons. He is the only other founder with significant weight. The remaining three (Gueniffey, Bartos, Mihalovic) don’t carry enough to act as a counterweight on their own.

The CTO steps down from his operational role in October 2024. No press release. Nine months later, in the summer of 2025, a settlement agreement is signed. The wording is legally precise: there was a dispute, and the parties settled. Its subject fits on one line in the minutes: governance, the valuation of the shares, the terms of departure. Not an amicable exit.

The following month, the 5 partners vote unanimously for the company to buy back all of Da Ros’s shares. Price: €395K, which implies a valuation of Galeon of around €2.63M. A company that had €324K in the bank at 31 December 2024 spends nearly all its cash buying out its co-founder, cancelling his shares and clearing the way. That partly explains the urgency to raise money: as early as June 2025, Galeon opens two bond issues of €2M each, one reserved for a small circle of investors46, the other for qualified investors (minimum ticket €100K). Da Ros leaves at a 25% discount to book equity: for someone who knew everything from the inside, that’s an exit price, not a price of conviction. And Brotons mechanically goes from 62% to 73% of the capital, sole master on board.

In December, it all moves fast: a check of the equity on a sample basis47 (not a full audit), conversion from SAS to SA, three directors on the board (Brotons, Bartos, Gueniffey48), and Brotons elected chairman of the board and chief executive. The result: a single man combines the chairmanship, the chief executive role, 73% of the capital, the exclusive power to issue debt49, and a veto over the arrival of any new shareholder50. No statutory auditor. No minority shareholder of any weight. No independent board.

Except that this information will never really be brought to the attention of the private individuals Galeon will try to win over from January 2026, apart from what is in the articles of association. Because the regulations offer quite a few options. Below €5M, Galeon could for instance have raised from the public through a PSFP, a licensed crowdfunding platform: except that the platform does its due diligence, checks the accounts and displays the risks. Asked about it, a well-known crowdfunding platform said plainly it would have turned the file down51. Above €8M, you need a prospectus approved by the AMF. Galeon chose a third way: the OPTF, a public offer of securities52, with a DIS53, a document the issuer writes itself and files with the AMF without the AMF approving it. No checks, no approval, no intermediary. Just an entirely in-house circuit: the company distributes its own bonds on its own platform (Atlantis), KYC is outsourced to Sumsub, card payments go through Stripe, and transfers above €5,000 appear to land directly with Galeon.

The only relays between the issuer and the public are sponsored content, technically labelled as such, but formatted like articles or editorial interviews: Legend, Europe 154 (a French national radio station), aggressive Facebook ads (whose content breaks the AMF’s guidelines on promotional communication for financial products), sponsored newsletters, the Pioneers. While I was writing this investigation, the head of a financial education platform contacted me of his own accord: he had had Galeon in his sights since the ICO and had refused to relay the bond offer, which he had received several times, at least once from someone identifiable as a Pioneer. The head of another platform had alerted me a few days earlier, after being retargeted for days by Galeon ads. Still on the marketing budget: the publisher of a personal finance newsletter had agreed to run an ad for the offer, then deleted it after receiving my information, feeling he had been duped.

A selection of the highly problematic ads run by Galeon.

The reason is that he looked, like most people, at the packaging. Because the only way to get real information is to read the DIS, between the lines included: 85 arid pages, plus appendices. A motivated individual who read it in full would find neither the price paid for Da Ros’s shares, nor the settlement agreement, nor the implied valuation of €2.63M. But most won’t read it. And those who do are not equipped to draw the conclusions, which require in-depth research and a certain amount of knowledge.

Because on Atlantis, on Legend, in the sponsored press, the figures on display are reassuring: 18 hospitals, 3 million patients, more than 40 employees, growing revenue, 8% annual interest. It isn’t entirely false. But it’s a lot more complicated. As so often.

Galeon chose to keep part of its annual accounts confidential. And not to appoint a statutory auditor, even though nothing stopped it from appointing one voluntarily before asking the public for €8M. Which, as I have said here several times (in French), should be a legal requirement: when you raise debt from private individuals, your accounts should be audited and public. They aren’t. And in its own forecast, the company lists revenue and ICO income on two separate lines, proof that it knows they are two different things. But in the published accounts, in its communications, on Legend, everything is lumped into a single figure. Five million in revenue.

By cross-checking a large number of documents, public or not, you can arrive at this accounting summary.

Two possible readings.

  • The first is the one Galeon shows: revenue that goes from €41K to €5M, net profit that rises every year, a growing company. That’s what a subscriber sees.
  • The second you have to know how to look for. And Galeon does nothing to help you find it. It comes down to three lines on the balance sheet: deferred income (money collected for a service not yet delivered), marketable securities (here, the crypto-assets held by the company), and trade receivables (the real invoices sent to hospitals).

And here is the detail of that other reading.